Business Segments · Selling, general, and administrative expense

Cardiovascular — Selling, general, and administrative expense

Medtronic Cardiovascular — Selling, general, and administrative expense decreased by 1.2% to $1.13B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.8%, from $1.01B to $1.13B. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ1 2026
Rolls up toSG&A

How to read this metric

Lower expenses relative to sales indicate high operational leverage, while rising expenses may signal aggressive market expansion or inefficiency.

Detailed definition

This includes all operating expenses for the cardiovascular segment related to sales, marketing, and general administrat...

Peer comparison

Comparable to SG&A expenses in the cardiovascular divisions of global medical device competitors.

Metric ID: mdt_segment_cardiovascular_selling_general_and_administrative_expense

Historical Data

11 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$663.25M$663.25M$663.25M$663.25M$978.00M$1.02B$1.01B$1.19B$1.06B$1.14B$1.13B
QoQ Change+0.0%+0.0%+0.0%+47.5%+4.4%-1.1%+18.0%-11.1%+7.8%-1.2%
YoY Change+47.5%+53.9%+8.4%+11.9%+11.8%
Range$663.25M$1.19B
CAGR+23.7%
Avg YoY Growth+26.7%
Median YoY Growth+11.9%

Frequently Asked Questions

What is Medtronic's cardiovascular — selling, general, and administrative expense?
Medtronic (MDT) reported cardiovascular — selling, general, and administrative expense of $1.13B in Q1 2026.
How has Medtronic's cardiovascular — selling, general, and administrative expense changed year-over-year?
Medtronic's cardiovascular — selling, general, and administrative expense increased by 11.8% year-over-year, from $1.01B to $1.13B.
What does cardiovascular — selling, general, and administrative expense mean?
The total cost of selling, marketing, and administrative support for the cardiovascular business.